Search results
S&P 500 (SPX) today: Bath & Body Works, Inc. is a top mover, up 3.01%
USA Today· 13 hours agoThe S&P 500 opened today at 5,221.10. Within 30 minutes of trading, the benchmark index rose by 3.09...
Earnings call: Innovid outlines robust Q1 growth, launches Harmony initiative
Investing.com· 2 days agoInnovid Inc. (CTV), a leading provider of advertising software solutions, has announced strong...
Upcoming US election and equity implications from JPMorgan
Investing.com· 7 days agoThe upcoming U.S. presidential election looks set to be a divisive, closely fought contest, and...
PRIMECAP Management's Strategic Exits and Acquisitions in Q1 202
Guru Focus· 16 hours agoInsightful Analysis of PRIMECAP's Latest 13F Filing Founded in 1983, PRIMECAP Management (Trades, Portfolio) is a distinguished investment management firm base
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 5 days agoNKTR regained full rights to rezpeg from Eli Lily (LLY) in April 2023 and took charge of its...
Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season
InvestorPlace· 4 days agoDepending on where you look, there has been quite a tough crowd of investors to please this earnings...
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Zacks· 6 days agoFree Report) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market. Retail and ...
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
InvestorPlace· 2 days agoHigh interest rates are here to stay. Federal Reserve Chairman Jerome Powell said the fight against...
Which Healthcare Stock Is A Better Pick – UnitedHealth Group Or CVS Health?
Forbes· 23 hours ago) is currently a better pick over its peer UnitedHealth Group stock, given its attractive valuation....
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 23 hours agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...